25 results
AI approaches for the discovery and validation of drug targets
-
- Journal:
- Cambridge Prisms: Precision Medicine / Volume 2 / 2024
- Published online by Cambridge University Press:
- 24 May 2024, e7
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Stability-based approaches in chemoproteomics
- Part of
-
- Journal:
- Expert Reviews in Molecular Medicine / Volume 26 / 2024
- Published online by Cambridge University Press:
- 12 April 2024, e6
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Anti-Toxoplasma gondii screening of MMV pandemic response box and evaluation of RWJ-67657 efficacy in chronically infected mice
-
- Journal:
- Parasitology / Volume 150 / Issue 13 / November 2023
- Published online by Cambridge University Press:
- 20 October 2023, pp. 1226-1235
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Cell painting transfer increases screening hit rate
-
- Journal:
- Biological Imaging / Volume 3 / 2023
- Published online by Cambridge University Press:
- 03 March 2023, e4
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
6 - Artificial Intelligence in Alzheimer’s Drug Discovery
- from Section 1 - Advancing Alzheimer’s Disease Therapies in a Collaborative Science Ecosystem
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 62-72
-
- Chapter
- Export citation
38 - SPARKing Drug Development for Alzheimer’s Disease in Academia
- from Section 5 - Academic Drug-Development Programs
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 437-448
-
- Chapter
- Export citation
8 - Use of Induced Pluripotent Stem Cell-Derived Neuronal Disease Models from Patients with Familial Early-Onset Alzheimer’s Disease in Drug Discovery
- from Section 2 - Non-clinical Assessment of Alzheimer’s Disease Candidate Drugs
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 95-105
-
- Chapter
- Export citation
9 - Preclinical Longitudinal In Vivo Biomarker Platform for Alzheimer’s Disease Drug Discovery
- from Section 2 - Non-clinical Assessment of Alzheimer’s Disease Candidate Drugs
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 106-122
-
- Chapter
- Export citation
5 - Repurposed Agents in Alzheimer’s Disease Drug Development
- from Section 1 - Advancing Alzheimer’s Disease Therapies in a Collaborative Science Ecosystem
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 54-61
-
- Chapter
- Export citation
A validated high-throughput method for assaying rat lungworm (Angiostrongylus cantonensis) motility when challenged with potentially anthelmintic natural products from Hawaiian fungi
-
- Journal:
- Parasitology / Volume 149 / Issue 6 / May 2022
- Published online by Cambridge University Press:
- 03 March 2022, pp. 765-773
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
6 - Fostering R&D of novel antibiotics and other technologies to prevent and treat infection
-
-
- Book:
- Challenges to Tackling Antimicrobial Resistance
- Published online:
- 21 March 2020
- Print publication:
- 23 April 2020, pp 125-154
-
- Chapter
-
- You have access
- Open access
- HTML
- Export citation
3 - The Biotechnology Sector: Therapeutics
-
-
- Book:
- The Business of Healthcare Innovation
- Published online:
- 24 February 2020
- Print publication:
- 12 March 2020, pp 89-302
-
- Chapter
- Export citation
Caenorhabditis elegans: nature and nurture gift to nematode parasitologists
-
- Journal:
- Parasitology / Volume 145 / Issue 8 / July 2018
- Published online by Cambridge University Press:
- 06 December 2017, pp. 979-987
-
- Article
- Export citation
Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
-
- Journal:
- Parasitology / Volume 145 / Issue 2 / February 2018
- Published online by Cambridge University Press:
- 14 August 2017, pp. 219-236
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
The trypanosome alternative oxidase: a potential drug target?
-
- Journal:
- Parasitology / Volume 145 / Issue 2 / February 2018
- Published online by Cambridge University Press:
- 29 November 2016, pp. 175-183
-
- Article
- Export citation
The marine biodiscovery pipeline and ocean medicines of tomorrow
-
- Journal:
- Journal of the Marine Biological Association of the United Kingdom / Volume 96 / Issue 1 / February 2016
- Published online by Cambridge University Press:
- 19 January 2016, pp. 151-158
-
- Article
-
- You have access
- HTML
- Export citation
From genomics to proteomics: new directions in molecular neuropsychiatry
-
- Journal:
- Acta Neuropsychiatrica / Volume 15 / Issue 6 / December 2003
- Published online by Cambridge University Press:
- 24 June 2014, pp. 388-397
-
- Article
- Export citation
Open source drug discovery – A limited tutorial
-
- Journal:
- Parasitology / Volume 141 / Issue 1 / January 2014
- Published online by Cambridge University Press:
- 28 August 2013, pp. 148-157
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter
-
- Journal:
- Parasitology / Volume 141 / Issue 1 / January 2014
- Published online by Cambridge University Press:
- 09 August 2013, pp. 28-36
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
-
- Journal:
- Parasitology / Volume 141 / Issue 1 / January 2014
- Published online by Cambridge University Press:
- 18 July 2013, pp. 119-127
-
- Article
-
- You have access
- Open access
- HTML
- Export citation